Literature DB >> 20583856

Nantenine as an acetylcholinesterase inhibitor: SAR, enzyme kinetics and molecular modeling investigations.

Stevan Pecic1, Marie A McAnuff, Wayne W Harding.   

Abstract

Nantenine, as well as a number of flexible analogs, were evaluated for acetylcholinesterase (AChE) inhibitory activity in microplate spectrophotometric assays based on Ellman's method. It was found that the rigid aporphine core of nantenine is an important structural requirement for its anticholinesterase activity. Nantenine showed mixed inhibition kinetics in enzyme assays. Molecular docking experiments suggest that nantenine binds preferentially to the catalytic site of AChE but is also capable of interacting with the peripheral anionic site (PAS) of the enzyme, thus accounting for its mixed inhibition profile. The aporphine core of nantenine may thus be a useful template for the design of novel PAS or dual-site AChE inhibitors. Inhibiting the PAS is desirable for prevention of aggregation of the amyloid peptide Aβ, a major causative factor in the progression of Alzheimer's disease (AD).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583856      PMCID: PMC4663080          DOI: 10.3109/14756361003671078

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  63 in total

Review 1.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

2.  Organocatalytic asymmetric total synthesis of (R)-rolipram and formal synthesis of (3S,4R)-paroxetine.

Authors:  Peter S Hynes; Paul A Stupple; Darren J Dixon
Journal:  Org Lett       Date:  2008-03-07       Impact factor: 6.005

Review 3.  Blood-brain barrier permeability considerations for CNS-targeted compound library design.

Authors:  Stephen A Hitchcock
Journal:  Curr Opin Chem Biol       Date:  2008-04-22       Impact factor: 8.822

Review 4.  The cholinergic hypothesis--ten years on.

Authors:  E K Perry
Journal:  Br Med Bull       Date:  1986-01       Impact factor: 4.291

5.  Influence of deteriorating ability of emotional comprehension on interpersonal behavior in Alzheimer-type dementia.

Authors:  A Shimokawa; N Yatomi; S Anamizu; S Torii; H Isono; Y Sugai; M Kohno
Journal:  Brain Cogn       Date:  2001-12       Impact factor: 2.310

6.  A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation.

Authors:  G V De Ferrari; M A Canales; I Shin; L M Weiner; I Silman; N C Inestrosa
Journal:  Biochemistry       Date:  2001-09-04       Impact factor: 3.162

Review 7.  Acetylcholinesterase interaction with Alzheimer amyloid beta.

Authors:  Nibaldo C Inestrosa; Juan Paulo Sagal; Marcela Colombres
Journal:  Subcell Biochem       Date:  2005

8.  Do cholinergic therapies have disease-modifying effects in Alzheimer's disease?

Authors:  Marwan N Sabbagh; Martin R Farlow; Normal Relkin; Thomas G Beach
Journal:  Alzheimers Dement       Date:  2006-04       Impact factor: 21.566

Review 9.  From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease.

Authors:  Maria Laura Bolognesi; Anna Minarini; Michela Rosini; Vincenzo Tumiatti; Carlo Melchiorre
Journal:  Mini Rev Med Chem       Date:  2008-09       Impact factor: 3.862

10.  11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.

Authors:  M H Hedberg; T Linnanen; J M Jansen; G Nordvall; S Hjorth; L Unelius; A M Johansson
Journal:  J Med Chem       Date:  1996-08-30       Impact factor: 7.446

View more
  11 in total

1.  Aporphinoid antagonists of 5-HT2A receptors: further evaluation of ring A substituents and the size of ring C.

Authors:  Shashikanth Ponnala; Nirav Kapadia; Hernán A Navarro; Wayne W Harding
Journal:  Chem Biol Drug Des       Date:  2014-06-03       Impact factor: 2.817

2.  Cytotoxicity of aporphines in human colon cancer cell lines HCT-116 and Caco-2: an SAR study.

Authors:  Shashikanth Ponnala; Sandeep Chaudhary; Antonio González-Sarrias; Navindra P Seeram; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2011-06-15       Impact factor: 2.823

3.  Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats.

Authors:  Jacob K Akintunde; C Abigail Irechukwu
Journal:  Ther Adv Drug Saf       Date:  2016-07-22

4.  Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability.

Authors:  Stevan Pecic; Amir A Zeki; Xiaoming Xu; Gina Y Jin; Shuwei Zhang; Sean Kodani; Marlin Halim; Christophe Morisseau; Bruce D Hammock; Shi-Xian Deng
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-03-20       Impact factor: 3.072

5.  New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.

Authors:  Sandeep Chaudhary; Shashikanth Ponnala; Onica Legendre; Junior A Gonzales; Hernán A Navarro; Wayne W Harding
Journal:  Bioorg Med Chem       Date:  2011-08-18       Impact factor: 3.641

6.  Synthesis, kinetic evaluation and molecular docking studies of donepezil-based acetylcholinesterase inhibitors.

Authors:  Makar Makarian; Michael Gonzalez; Stephanie M Salvador; Shahrokh Lorzadeh; Paula K Hudson; Stevan Pecic
Journal:  J Mol Struct       Date:  2021-09-03       Impact factor: 3.196

7.  C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.

Authors:  Nirav Kapadia; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2015-07-11       Impact factor: 2.823

8.  A New Route to Azafluoranthene Natural Products via Direct Arylation.

Authors:  Shashikanth Ponnala; Wayne W Harding
Journal:  European J Org Chem       Date:  2013-01-03

9.  New therapeutic approaches and novel alternatives for organophosphate toxicity.

Authors:  Francine S Katz; Stevan Pecic; Laura Schneider; Zhengxiang Zhu; Ashley Hastings; Michal Luzac; Joanne Macdonald; Donald W Landry; Milan N Stojanovic
Journal:  Toxicol Lett       Date:  2018-03-31       Impact factor: 4.372

10.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.